Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS reform

This article was originally published in The Gray Sheet

Executive Summary

Medicare Office of Technology and Innovation should be created at agency to publish data on coverage decisions and denials, offer responses to inquiries by hospitals and manufacturers, AdvaMed says in supporting Bush Administration's Medicare reform principles, announced July 12. Independent office would be headed by appointee from outside the agency and may be established administratively by CMS

You may also be interested in...



CMS Device Coverage, Coding Accountability Office Would Be Legislated

Device industry reps expect House Ways & Means Committee member Jim Ramstad (R-Minn.) to introduce legislation the week of July 23 that would create a Medicare Office of Technology and Innovation at CMS.

US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.

UsernamePublicRestriction

Register

MT015141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel